A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma

Clinical trial NCT05565391 · COMPLETED

Trial details

NCT number: NCT05565391
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2022-10-03
Primary completion: 2022-11-04
Enrollment: 508

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.